Deutsche Bank Starts Entellus Medical (ENTL) at Buy

October 6, 2016 7:35 AM EDT
Get Alerts ENTL Hot Sheet
Price: $20.26 -1.46%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 20 | New: 30
Trade ENTL Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Deutsche Bank initiated coverage on Entellus Medical (NASDAQ: ENTL) with a Buy rating and a price target of $26. Analyst Brittany Henderson said she sees upside from current levels as the company continues to enable the shift of procedures from the operating room to the physician’s office.

"We view Entellus as a key player in the ENT space with sustainable double digit sales growth and high gross margins expected over the coming years driven primarily by two factors: the shift from operating room based procedures to physician’s office based procedures and the shift from functional endoscopic sinus surgery (FESS) to balloon sinus dilation, a minimally invasive alternative," said Henderson.

For an analyst ratings summary and ratings history on Entellus Medical click here. For more ratings news on Entellus Medical click here.

Shares of Entellus Medical closed at $22.12 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, New Coverage

Related Entities

Deutsche Bank

Add Your Comment